Aldeyra Therapeutics Inc. (ALDX) Statistics & Valuation Metrics - Stocknear

Aldeyra Therapeutics Inc.

NASDAQ: ALDX · Real-Time Price · USD
5.53
-0.30 (-5.15%)
At close: Sep 04, 2025, 3:59 PM
5.83
5.42%
After-hours: Sep 04, 2025, 07:58 PM EDT

Aldeyra Therapeutics Statistics

Share Statistics

Aldeyra Therapeutics has 59.9M shares outstanding. The number of shares has increased by 0.8% in one year.

59.9M
0.8%
0.31%
63.26%
58.17M
1,725
0.17%

Short Selling Information

The latest short interest is 4.99M, so 8.33% of the outstanding shares have been sold short.

4.99M
8.33%
8.59%
5.19

Valuation Ratios

The PE ratio is -5.31 and the forward PE ratio is 38.87. Aldeyra Therapeutics's PEG ratio is -0.11.

-5.31
38.87
0
4.2
4.18
-6.87
-0.11
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Aldeyra Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.59, with a Debt / Equity ratio of 0.22.

5.59
5.59
0.22
-0.29
-0.35
-31.21

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-6.21M
9
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -12.5% in the last 52 weeks. The beta is 0.75, so Aldeyra Therapeutics's price volatility has been higher than the market average.

0.75
-12.5%
5.1
4.56
52.61
1,015,553

Income Statement

n/a
-249.62K
-60.12M
-55.85M
-53.68M
-53.93M
-0.94
Full Income Statement

Balance Sheet

The company has 54.53M in cash and 15.3M in debt, giving a net cash position of 39.22M.

54.53M
15.3M
39.22M
-450.11M
84.96M
55.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.21M and capital expenditures 0, giving a free cash flow of -43.21M.

-43.21M
n/a
-43.21M
-0.73
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

ALDX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ALDX is $9.5, which is 71.8% higher than the current price. The consensus rating is "Buy".

$9.5
71.8%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-1.78
1